Benzinga Biotech Small Cap Conference: Immutep Limited (ASX:IMM, NASDAQ:IMMP) March 24, 2021

BZreplay: Benzinga Biotech Small Cap Conference | Innovative & Emerging TherapiesПодробнее

Biotech Unlocked - IMMUTEP ASX:IMMПодробнее

Immutep Limited (ASX:IMM; NASDAQ:IMMP) CEO and Executive Director Marc Voigt provides company updateПодробнее

Immutep (ASX:IMM; NASDAQ: IMMP) Company Update On Start Of 2021Подробнее

From the helm: Immutep's (ASX:IMM, NASDAQ:IMMP) Executive Director & CEO Marc VoigtПодробнее

Benzinga Biotech Small Cap Conference | Immunology and Unmet Medical Needs | March 25Подробнее

Stock of the Day: ImmutepПодробнее

Benzinga Biotech Small Cap Conference | Innovative & Emerging Therapies | March 25Подробнее

Immutep (ASX:IMM, NASDAQ:IMMP) discusses a transformative year for LAG-3 therapiesПодробнее

Immutep (ASX:IMM, NASDAQ:IMMP) reports positive discussions with the FDA and strong survival dataПодробнее

AUSBIZ Interview with CEO Marc Voigt, March 17, 2021, Immutep Limited (ASX: IMM; NASDAQ: IMMP)Подробнее

Immutep (ASX:IMM, NASDAQ:IMMP) reports first subject dosed in autoimmune disease studyПодробнее

Immutep (ASX:IMM, NASDAQ:IMMP) receives fast track designation from FDA - October 12, 2022Подробнее

Immutep (ASX:IMM, NASDAQ:IMMP) Webcast for TACTI-002 Data Presented at ASCO 2022 - 10 Jun 2022Подробнее

Immutep Limited (ASX:IMM, NASDAQ:IMMP) - Reflecting on progress and partnerships at ImmutepПодробнее

Immutep (ASX:IMM, NASDAQ:IMMP) Global Webcast Presentation at SITC 2022Подробнее